Avapritinib
Spécifications
1703793-34-3Numéro CAS
(1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamineNom IUPAC
C26H27FN10Formule chimique
498.6 g/molMasse molaire
Avapritinib; 1703793-34-3; BLU-285; Ayvakit; (1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine; 513P80B4YJ; C-366; 70C366; DTXSID301027935; X720776; X-720776; (1S)-1-(4-fluorophenyl)-1-(2-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl}pyrimidin-5-yl)ethan-1-amine; (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO(2,1-F)(1,2,4)TRIAZIN-4-YL)PIPERAZIN-YL)PYRIMIDIN-5-YL)ETHAN-1-AMINE; avapritinibum; (1S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO(2,1-F)(1,2,4)TRIAZIN-4-YL)PIPERAZIN-1-YL)PYRIMIDIN-5-YL)ETHAN-1-AMINE; (1S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methylpyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethanamine; (1S)-1-(4-fluorophenyl)-1-(2-{4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl}pyrimidin-5-yl)ethanamine; RefChem:56916; DTXCID501513502; CS3007; PDGFR alpha/KIT Mutant-specific Inhibitor BLU-285; (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1Hpyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)piperazin-yl)pyrimidin-5-yl)ethan-1-amine; 5-PYRIMIDINEMETHANAMINE, alpha-(4-FLUOROPHENYL)-alpha-METHYL-2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO(2,1-F)(1,2,4)TRIAZIN-4-YL)-1-PIPERAZINYL)-, (alphaS)-; MFCD31544325; Avapritinib [INN]; BLU285; (S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethan-1-amine; BLU-285 (Avapritinib); (1S)-1-(4-Fluorophenyl)-1-(2-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-1-piperazinyl}-5-pyrimidinyl)ethanamine; Ayvakyt; (1S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-5-pyrimidinyl)ethanamine; 9JI; Ayvakit (TN); Ayvakyt (TN); Avapritinib (Standard); AVAPRITINIB [MI]; Avapritinib (USAN/INN); AVAPRITINIB [USAN]; AVAPRITINIB [WHO-DD]; UNII-513P80B4YJ; orb1225956; orb1302083; CHEMBL4204794; SCHEMBL16652297; GTPL10368; AVAPRITINIB [ORANGE BOOK]; BLU 285; BDBM469269; C26H27FN10; (S)-alpha-(4-Fluorophenyl)-alpha-methyl-2-[4-[6-(1-methyl-4-pyrazolyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]-1-piperazinyl]pyrimidine-5-methanamine; EX-A1366; US10807985, Compound 44; EBC-27235; NSC801082; AKOS037648993; CCG-269677; CS-7577; DB15233; HY-101561R; NSC-801082; NCGC00537948-02; NCGC00537948-03; AC-31598; BB166456; BS-16206; SY122762; HY-101561; T5109; D11279; EN300-25382569; Q29213676; (1~{S})-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine; (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl)piperazin-1-yl)pyrimidin-5-yl)ethanamine; 5-PYRIMIDINEMETHANAMINE, .ALPHA.-(4-FLUOROPHENYL)-.ALPHA.-METHYL-2-(4-(6-(1-METHYL-1H-PYRAZOL-4-YL)PYRROLO(2,1-F)(1,2,4)TRIAZIN-4-YL)-1-PIPERAZINYL)-, (.ALPHA.S)-Synonymes
Produits contenant Avapritinib
AYVAKYT 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAYVAKYT 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAYVAKYT 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAYVAKYT 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAYVAKYT 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULAAYVAKYT 50 mg, comprimé pelliculéAYVAKYT 300 mg, comprimé pelliculéAYVAKYT 25 mg, comprimé pelliculéAYVAKYT 200 mg, comprimé pelliculéAYVAKYT 100 mg, comprimé pelliculéAvapritinibAvapritinib